相关实验视频

Updated: Jul 17, 2025

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

针对瘤血管生成的天然产品

Xiaohua Lu¹, Lara Johanna Friedrich¹, Thomas Efferth¹

¹Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University Mainz, Mainz, Germany.

British journal of pharmacology

|September 8, 2023

概括

天然产品在抑制瘤血管生成方面表现有前途,抑制瘤血管生成,即新血管的形成,这些血管为癌症生长提供食物. 本综述探讨了抗血管原性天然剂及其开发新型癌症疗法的潜力.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
自然产品化学化学

背景情况:

瘤血管生成对于癌症的进展和转移至关重要.
向瘤血管生成是癌症治疗的一个关键策略.
自然产品提供了丰富的抗血管生成化合物的来源.

研究的目的:

审查天然产品对抗瘤血管生成的现状.
探索各种抗血管原性天然剂的作用机制.
讨论天然产品在抗血管性癌症药物开发中的未来前景.

主要方法:

综合文献综述至2023年3月.
对瘤血管生成中的亲血管原和抗血管原因素的分析.
自然抗血管原剂的分类和机制阐明 (多,多糖,类,类,类,沙素).
审查当前的抗瘤血管生成疗法 (单克隆抗体,小分子,融合蛋白).

主要成果:

自然产品,包括多,多糖,类,类和沙素,具有显著的抗血管性质.
这些天然剂通过各种机制起作用,抑制瘤血管形成.
该审查总结了既有和新兴的抗血管生成疗法.

结论:

自然产品在开发新型抗血管原性癌症药物方面具有巨大的潜力.
需要进一步的研究来改善生物可用性,优化剂量,并评估这些药物的副作用.
组合疗法和发现独特的天然化合物是临床转化未来有希望的方向.

关键词:

使用VEGFR-2抑制剂.自然产品是自然产品的产品.植物化学品植物化学品有针对性的化疗.瘤血管生成瘤血管生成

更多相关视频

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis

Published on: June 24, 2019

相关概念视频

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...